Increased Doses of Oral Semaglutide Can Induce Pronounced Weight Loss, Improve Glycemic Control
Data from a pair of trials presented at ADA 2023 suggests an upped dose of oral semaglutide could soon be on the horizon, with results supporting use in chronic weight management as well as type 2 diabetes.
Source: hcplive.com